Noopept (NP)

GVS-111; N-Phenylacetyl-L-Prolylglycine Ethyl Ester

Noopept is a peptide promoted and prescribed in Russia and neighbouring countries as a nootropic. Animal studies have shown noopept to be neuroprotective and enhance memory in various tests. Since it is a peptide-derived compound, noopept is degraded by enzymes in the GI tract and liver. It does show good blood–brain barrier penetration in rats, and human studies have shown promising results, with potential application in the treatment of Alzheimer's disease. It is also an "immunocorrector" in mice. It has been found to stimulate the expression of NGF and BDNF in rat hippocampus. Expression of the studied neurotropic factors in the cerebral cortex was below the control after single administration of Noopept, while chronic administration caused a slight increase in BDNF expression. In Russia, Noopept is considered a nootropic drug with neuroprotective properties.

Organism species: Pan-species (General)

Proteins n/a Complete Antigen of Noopept (NP) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Noopept (NP) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Noopept (NP) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Noopept (NP) CLIA Kit Customized Service Offer
n/a ELISA Kit for Noopept (NP) ELISA Kit Customized Service Offer